Skip to content

Opinion

Retail evolution bodes well for nonprescription meds

Retail evolution bodes well for nonprescription meds

Changes on the retail scene bode well for the consumer health care products market because they show that chains are trying to stay engaged with their customers, says Consumer Healthcare Products Association (CHPA) chairman and Clarion Brands chief executive officer Gary Downing.

NACDS RxImpact Day part of ongoing dialogue

NACDS RxImpact Day part of ongoing dialogue

for the policy makers and pharmacy advocates who participated, the pharmacy profession as a whole and, ultimately, patients across the country — came into sharp focus during the daylong series of meetings on Capitol Hill that is

Industry strengthened by NACDS events

Industry strengthened by NACDS events

The National Association of Chain Drug Stores is gearing up for three big events in the coming months, each of which will offer stakeholders in community pharmacy an opportunity to advance the interests of their organization and the industry as a whole.

CVS-Aetna: A blockbuster in vertical integration

CVS-Aetna: A blockbuster in vertical integration

which totaled $72 billion in 2016 and $76 billion after the third quarter of 2017, prior to CVS announcing the final deal. Across the industry, companies are increasingly leveraging these strategic partnerships to improve